大家都知道"吃头孢不能喝酒" 但许多人并不知道这背后的原理 其实除了头孢以外 喝酒还会放大多种药物的副作用 后果可能很严重 小酌怡情，喝多伤身 如果非想喝点酒 这些要点千万别忘记 吃了这几种药 千万别喝酒 1 抗菌药物（头孢类等） 大部分头孢类药物都含有类似双硫仑化学结构的甲硫四氮唑基团，若在服药前后饮酒，可能会导致双硫仑样反应，出现面部潮红、结膜充血、视物模糊、头 颈部血管剧烈搏动或搏动性头痛、头晕、恶心、呕吐、呼吸困难、惊厥，甚至死亡等。 除此之外，还有很多抗菌药物都和酒是"世仇"，例如： 喹诺酮类：左氧氟沙星、莫西沙星、诺氟沙星；大环内酯类：琥乙红霉素、红霉素。 硝基咪唑类：甲硝唑、替硝唑。 硝基呋喃类：呋喃妥因、呋喃唑酮、硝呋太尔。 抗真菌类：酮康唑、灰黄霉素。 抗结核类：异烟肼。 磺胺类：复方磺胺甲噁唑。 2 非甾体抗炎药 例如：解热和镇痛的对乙酰氨基酚、布洛芬、阿司匹林等。 这类药若遇上酒精，可能增加肝毒性，引起胃黏膜病变，或胃溃疡复发，增加上消化道出血风险。 酒精会加速这类药物的吸收速度，同时降低代谢速度，再加上酒精对中枢神经系统有抑制作用，可能会加强镇静催眠药的作用，引发严重后果。 5 降压药 ...

Core Viewpoint - The discussion highlights the risks associated with using expired medications, emphasizing that both Western and traditional Chinese medicines can pose health hazards when past their expiration dates [1][3][4]. Group 1: Risks of Expired Medications - Expired medications can lose their efficacy and may even lead to adverse health effects, particularly for chronic disease patients [1][2]. - Certain medications, like antibiotics, may become ineffective or harmful after expiration, potentially worsening health conditions [1][2]. - The chemical breakdown of some drugs can produce harmful substances, such as aspirin degrading into salicylic acid, which can irritate the gastrointestinal tract [2]. Group 2: Risks of Expired Traditional Chinese Medicine (TCM) - Expired TCM can also pose health risks, as the complex components may generate unknown harmful substances [3]. - The notion that some TCMs improve with age is misleading; most do not benefit from long-term storage and can lose potency or become unsafe [3][4]. - The Chinese regulatory body has mandated that TCM products must display expiration dates starting from August 2025 to ensure safety and efficacy [3]. Group 3: Proper Disposal and Management of Medications - It is recommended to categorize expired medications for disposal, with specific guidelines for solid, liquid, and injectable forms [5][6]. - Regular cleaning of medicine cabinets every 3-6 months is advised to remove expired products and maintain an updated inventory [7]. - Proper storage conditions for medications are crucial, requiring a dry and light-protected environment [8].

来源：人民日报健康客户端 春节聚会，推杯换盏、把酒言欢——热闹是真的，但身体在"悄悄加班"也是真的。你以为酒精只是伤 胃？错。医生警告：酒精的伤害，远比你想的更可怕。肝脏、心脏、大脑、血管……一杯酒下去，全身 都在替你扛。 今天这篇文章，并非劝你一定要戒酒，而是劝你再别用错方式饮酒，这6种喝法太伤身。 这6种喝酒方式，危害翻倍 各种酒混在一起喝，首先就会让我们不自觉地饮酒过量。而且，两种以上的酒混着喝还会表现出某 种"协同作用"，对人体伤害更大。长沙市中心医院重症医学科主任医师杨勇2024年在医院微信公众号刊 文介绍，不同种类的酒精饮品混合饮用会加速酒精的吸收，增加肝脏和胃肠的负担，从而显著提高急性 酒精中毒的风险。② 1. 服药期间喝酒 正在服用药物的人可千万不能因为"兴致"，而忽视了酒与药同服的危害。中南大学湘雅二医院药学部主 管药师席洋2023年在医院微信公众号刊文提醒，若服用与酒精有相互作用的药物，应停药后至少间隔7 天再饮酒。老年人、肝肾功能不全等特殊人群间隔时间应延长。此外，喝酒后建议在3天内避免服用与 酒精有相互作用的药物。① 除了头孢不能与酒同时服用，还有其他一些药物服药期间也不能饮酒： 镇静 ...

Group 1 - A 30-year-old man in Nanjing experienced severe health complications after consuming alcohol while taking Metronidazole, leading to liver failure [1] - The patient was admitted with altered consciousness and strong alcohol odor, and after treatment, he developed hepatic encephalopathy, failing to recognize even his parents [1] - Medical staff managed to stabilize the patient after five days of intensive care, and he has since recovered and been discharged [1] Group 2 - Doctors warn against the dangerous combination of alcohol with certain medications, including Metronidazole and other drugs like hypoglycemics, antihypertensives, sedatives, and sleeping pills [1] - The principle of "do not drink alcohol while taking medication and do not take medication while drinking alcohol" is emphasized as a basic safety guideline [1]

Group 1 - A man in his 30s in Nanjing, Jiangsu, experienced liver failure after consuming metronidazole and alcohol, leading to a five-day hospitalization before stabilizing [1] - Medical professionals emphasize the dangers of combining metronidazole and alcohol, similar to the known risks of alcohol with cephalosporins [1] - The principle of "no alcohol with medication" is reiterated, highlighting that various medications, including antidiabetics, antihypertensives, sedatives, and sleeping pills, should not be mixed with alcohol [1]

Core Viewpoint - The use of medication among the elderly is a "double-edged sword," where it can either treat diseases or cause harm due to polypharmacy and improper medication management [1][2][3] Group 1: Current Situation of Elderly Medication - A significant portion of elderly individuals (over 60 years old) suffer from multiple chronic diseases, with nearly half having four or more chronic conditions [1] - Approximately 70% of elderly individuals in China take more than five types of medication daily, including prescribed drugs and over-the-counter supplements [1] - The complexity of medication regimens increases management difficulties and poses risks of drug interactions, which can lead to adverse effects such as liver and kidney damage [1][2] Group 2: Causes of Inappropriate Medication Use - There is a widespread misconception among the elderly that "more medication equals better treatment," leading to a lack of understanding of proper medication use [1][2] - Multiple consultations across different specialties often result in fragmented care, where each specialist prescribes medications without considering potential interactions [1][2] - The absence of adequate guidance on rational medication use from healthcare providers contributes to the problem [2] Group 3: Consequences of Inappropriate Medication Use - Inappropriate medication use is gradually undermining the health of the elderly, as their liver and kidney functions typically decline with age, making them more susceptible to medication-related issues [2] - Statistics indicate that approximately 1 in 7 elderly individuals die not from natural aging or diseases, but from inappropriate medication use [2] Group 4: Recommendations for Improvement - Healthcare providers should adopt a "precision medication" approach, ensuring thorough understanding of patients' medical histories to avoid unnecessary prescriptions [3] - Hospitals should implement medication assessment mechanisms for elderly patients with chronic diseases to regularly adjust their medication plans [3] - Community initiatives should focus on educating the elderly about rational medication use through health seminars and personalized consultations [3] - Families should discourage elderly individuals from purchasing unnecessary supplements and ensure they adhere to prescribed medication regimens [3] - Pharmaceutical companies should enhance the readability of medication instructions to cater to the elderly, making them clearer and more accessible [3]

Core Viewpoint - The introduction of the commercial insurance innovative drug directory will create a win-win situation for patients, insurance companies, and hospitals, allowing patients access to innovative drugs, insurance companies to benefit from discounts, and hospitals to enhance their diagnostic capabilities and influence [1][7]. Summary by Sections Commercial Insurance Directory Release - On December 7, the National Medical Insurance Administration released the adjusted national basic medical insurance directory and the first version of the commercial insurance innovative drug directory, adding 114 new drugs to the basic insurance directory and 19 drugs to the commercial insurance directory [2]. Support for Innovation - The National Medical Insurance Administration aims to clarify the boundaries of basic medical insurance coverage and leave room for the development of commercial insurance, focusing on supporting true and differentiated innovations rather than redundant innovations [3][15]. Drug Selection Criteria - The drugs included in the commercial insurance directory are characterized by high innovation, significant clinical value, non-replaceability by existing basic insurance drugs, and strong insurability [6][11]. Market Dynamics - The commercial insurance directory is expected to provide coverage primarily for high-cost treatments after second and third-line therapies, indicating that it is designed to supplement existing basic insurance rather than simply overlap with it [7][10]. Insurance Product Development - Insurance companies are encouraged to design products that align with the commercial insurance directory, focusing on specific populations and innovative drugs [8][10]. Challenges and Considerations - The main challenges for commercial insurance include improving the efficiency of claims processing, ensuring that products cover truly innovative drugs, and addressing the potential issue of adverse selection if sick individuals are more inclined to purchase insurance [12][13]. Future Outlook - The commercial insurance directory is expected to officially launch on January 1, 2026, with insurance companies likely to introduce corresponding products shortly thereafter [10][12]. Regulatory Support - The National Medical Insurance Administration is committed to supporting true innovation and has implemented stricter evaluation criteria for new drugs, resulting in a lower approval rate for submissions [16][18]. Financial Impact - As of October 2025, the medical insurance fund has paid over 460 billion yuan for negotiated drugs, benefiting over 1 billion patients and driving related sales exceeding 670 billion yuan, demonstrating substantial financial support for the development of innovative drugs [18].

Core Viewpoint - The article emphasizes the health risks associated with expired medications, highlighting misconceptions about their safety and efficacy, particularly regarding both Western and traditional Chinese medicines [1][2][3]. Group 1: Misconceptions about Expired Medications - There is a prevalent belief that expired medications are safe to consume if they have not visibly changed, which is incorrect [1]. - Some individuals think that Western medicines have expiration dates while traditional Chinese medicines do not, which is misleading [1][3]. Group 2: Health Risks of Expired Medications - Expired medications can not only lose their effectiveness but may also undergo chemical changes that produce harmful substances [2]. - For instance, expired antibiotics may lose their ability to combat infections, potentially worsening health conditions [2]. - Certain medications, like aspirin, can decompose into harmful compounds that may cause gastrointestinal issues [2]. Group 3: Regulations and Storage of Traditional Chinese Medicine - The National Medical Products Administration has mandated that traditional Chinese medicine products must display expiration dates starting August 1, 2025, to ensure safety and efficacy [3]. - Proper storage of traditional Chinese medicines is crucial, as improper conditions can lead to spoilage and loss of effectiveness [3][8]. Group 4: Importance of Proper Storage - Effective storage conditions are essential for maintaining the safety and efficacy of medications, with specific temperature and humidity requirements [7]. - Medications should be stored according to their instructions, and opened products should be used within a specified timeframe to avoid contamination [6][7]. Group 5: Recommendations for Home Medicine Management - Regularly cleaning out home medicine cabinets and disposing of expired or spoiled medications is advised [8]. - Traditional Chinese medicines should be categorized and stored appropriately to prevent moisture and pest damage [8].

Group 1 - The core viewpoint of the news is that Beilu Pharmaceutical's stock has experienced fluctuations, with a recent decline of 2.03% and a year-to-date increase of 41.46% [1] - As of November 18, the stock price is reported at 8.70 yuan per share, with a total market capitalization of 4.897 billion yuan [1] - The company has seen a net outflow of 15.135 million yuan in principal funds, with significant selling pressure from large orders [1] Group 2 - Beilu Pharmaceutical operates in the pharmaceutical and biological industry, specifically in chemical pharmaceuticals and preparations [2] - For the period from January to September 2025, the company achieved operating revenue of 873 million yuan, representing a year-on-year growth of 19.59%, and a net profit attributable to shareholders of 44.177 million yuan, up 81.10% year-on-year [2] - The company's main business revenue composition includes contrast agents (63.33%), traditional Chinese medicine (22.09%), and hypoglycemic drugs (12.75%) [1] Group 3 - Since its A-share listing, Beilu Pharmaceutical has distributed a total of 369 million yuan in dividends, with 59.0327 million yuan distributed over the past three years [3]

Core Insights - Young patients with type 2 diabetes often feel despair about lifelong medication, but with proper management, there is potential for reversal of the condition [1][3] - The management of diabetes in young patients differs from that in older patients, requiring tailored approaches to medication and lifestyle changes [1][2] Management Strategies - Young patients may struggle with medication adherence due to their busy schedules; therefore, doctors should create simplified medication regimens, such as once-daily dosing [1][2] - Weight management is crucial for treating type 2 diabetes, with a focus on dietary control and physical activity [2][3] - Dietary recommendations include controlling total intake, adjusting the order of food consumption, and eating slowly to prevent overeating [1][2] Psychological Support - Many young patients believe diabetes is a lifelong burden, leading to feelings of hopelessness; healthcare providers should encourage them that diabetes can be managed effectively [3] - Setting achievable goals and providing positive reinforcement can help improve patients' self-management and adherence to treatment [3] Treatment Outcomes - Some patients may achieve remission of diabetes, defined as maintaining normal blood sugar levels for over three months without medication, but this is not common [2] - Continuous monitoring and support are essential, as many patients may mistakenly believe they are cured and neglect their management, leading to complications [2][3]